MicroPort NeuroTech (HKSE:02172) Net Cash per Share : HK$1.28 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is MicroPort NeuroTech Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). MicroPort NeuroTech's Net Cash per Share for the quarter that ended in Dec. 2023 was HK$1.28.

The historical rank and industry rank for MicroPort NeuroTech's Net Cash per Share or its related term are showing as below:

HKSE:02172' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 6.46 Med: 12.75 Max: 15.94
Current: 6.46

During the past 5 years, the highest Price-to-Net-Cash Ratio of MicroPort NeuroTech was 15.94. The lowest was 6.46. And the median was 12.75.

HKSE:02172's Price-to-Net-Cash is ranked better than
52.16% of 324 companies
in the Medical Devices & Instruments industry
Industry Median: 7.195 vs HKSE:02172: 6.46

MicroPort NeuroTech Net Cash per Share Historical Data

The historical data trend for MicroPort NeuroTech's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort NeuroTech Net Cash per Share Chart

MicroPort NeuroTech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Cash per Share

-0.28

0.03

-1.94

1.44

1.28

MicroPort NeuroTech Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Cash per Share	Get a 7-Day Free Trial			-1.94	-2.07	1.44	1.55	1.28

Competitive Comparison of MicroPort NeuroTech's Net Cash per Share

For the Medical Devices subindustry, MicroPort NeuroTech's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroPort NeuroTech's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroTech's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where MicroPort NeuroTech's Price-to-Net-Cash falls into.

MicroPort NeuroTech Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

MicroPort NeuroTech's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

	Net Cash per Share (A: Dec. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1098.897	-	352.623	-	3.004)	/	582.658
=	1.28

MicroPort NeuroTech's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

	Net Cash per Share (Q: Dec. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1098.897	-	352.623	-	3.004)	/	582.658
=	1.28

MicroPort NeuroTech (HKSE:02172) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.

MicroPort NeuroTech Net Cash per Share Related Terms

Thank you for viewing the detailed overview of MicroPort NeuroTech's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort NeuroTech (HKSE:02172) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort NeuroTech Ltd (HKSE:02172) » Definitions » Net Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1661 Zhangdong Road, Pudong New Area, Shanghai, CHN

Website

https://www.medneurotech.com

MicroPort NeuroTech Ltd is into the neuro-interventional medical device industry, dedicated to providing innovative solutions for physicians and patients. The company boast a comprehensive portfolio of approved therapeutic products covering all of the three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.

Executives

Hu Yibin
Biolink Biomedical Ltd.	2201 Interest of corporation controlled by you
Blossom Vision Limited	2201 Interest of corporation controlled by you
Lion Fish Limited	2201 Interest of corporation controlled by you
Suntera Corporate Trustees (hong Kong) Limited	2301 Trustee
Thriving Hope Limited	2201 Interest of corporation controlled by you
Biolink Fund Limited Partnership	2201 Interest of corporation controlled by you
Biolink Limited	2101 Beneficial owner
Microport Scientific Corporation
Microport Scientific Investment Ltd
Maxwell Maxcare Science Foundation Limited
We'tron Capital Limited

MicroPort NeuroTech (HKSE:02172) Headlines

No Headlines